HD2A RASC-SUD Implementation Support Core
HD2A RASC-SUD 实施支持核心
基本信息
- 批准号:10596437
- 负责人:
- 金额:$ 59.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:Action ResearchAdoptionAdvocacyAfrican American populationAmericanAsian AmericansBehavior TherapyBlack raceCOVID-19 pandemicCaringCatalogsClinical Trials NetworkCommunitiesContinuity of Patient CareDataDeath RateDissemination and ImplementationEngineeringEvaluationFacultyFundingGoalsHarm ReductionHealthcareHealthcare SystemsHelping to End Addiction Long-termInterventionInvestmentsJusticeLeadLeadershipLearningLinkMeasuresMediationMethodologyMethodsMotivationNational Institute of Drug AbuseNative AmericansNative HawaiianNeedlesNot Hispanic or LatinoOpioidOverdoseOverdose reductionPacific IslanderPainPharmaceutical PreparationsPharmacologyPhasePoliciesPreventionPublic HealthPublic Health PracticePublicationsRecovery SupportResearchResearch InstituteResearch PersonnelResourcesRoleScienceScientistServicesSubstance Use DisorderSystemTechnology TransferTimeTranslatingTranslational ResearchUninsuredUnited States National Institutes of HealthUnited States Substance Abuse and Mental Health Services Administrationaddictionbasecaucasian Americandissemination scienceevidence basegaps in accesshealth equityimplementation facilitationimplementation interventionimplementation measuresimplementation outcomesimplementation researchimplementation scienceimplementation strategyimprovedinnovationknowledge basemarginalized populationopioid use disorderoverdose deathoverdose preventionoverdose riskprogram disseminationpsychosocialresource guidesshared decision makingsocial stigmasubstance use treatmentsymposium
项目摘要
This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to improve treatment for opioid misuse and addiction and to develop concrete strategies capable of providing rapid and durable solutions to the opioid crisis. SUD IMPLEMENTATION SUPPORT CORE: PROJECT SUMMARY/ABSTRACT Drug overdose fatalities have continued to rise despite massive federal investment in developing and disseminating evidence-based pharmacological and behavioral interventions for substance use disorders (SUDs). Attempts to move the needle on overdose deaths have stalled because of challenges translating research knowledge and evidence-based SUD interventions into public health practice. Access to evidence- based SUD interventions remains woefully limited throughout the U.S. health care system, particularly for historically marginalized populations such as Black/African-Americans, Native Hawaiians/Pacific Islanders, Asian Americans, and the uninsured. Equitable translation of research findings into practice is the domain of dissemination and implementation (D&I) science. A core component of the HD2A Research Adoption Support Center (RASC), the SUD Implementation Support (SUD-IS) Core will bring the best of D&I science to the Innovation Projects to guide the selection, implementation, and sustainment of evidence-based, locally appropriate SUD interventions to reduce overdose risk in hard hit communities. Core leadership will unify implementation scientists and SUD researchers - with the proximal goal of enhancing the impact of the Innovation Projects and the ultimate goal of improving public health - by leveraging cutting-edge D&I measures and methods, and capitalizing on our team’s commitment to team science. Thematically and operationally in tandem with the RASC and other cores, the SUD-IS Core will elevate the Innovation Projects through dynamic and iterative phases of ASSESS, ASSIST, and ADVANCE. We will first ASSESS the current state of evidence for SUD interventions in order to: a) develop a systematic catalog of evidence-based and emerging practices; and b) develop an SUD Intervention D&I Resource Guide for the Innovation Projects and any SUD intervention implementation project based on five key D&I constructs (e.g., contextual determinants, evidentiary support for the intervention, stakeholder engagement, implementation strategies, and implementation outcomes including equity and stigma). We will then ASSIST the Innovation Projects using information gathered in the ASSESS phase in order to: a) enhance motivation to enhance their studies with tailored D&I approaches that draw upon Core expertise; b) provide a D&I Implementation Support Plan and use a shared decision-making approach to determine how best to offer technical assistance; and c) co-lead the RASC Learning Collaborative. Finally, we will ADVANCE the Innovation Projects’ activities with respect to sustainment, equity, and stigma reduction: linking projects with the field at large, promoting impacts on policy/financing and facilitating ongoing stakeholder engagement towards advocacy. Perfectly aligned with the RASC, together we take a major step toward closing the persistent and inequitable gap of access to proven pharmacologic and psychosocial treatments for SUD.
这项研究是NIH的一部分,有助于长期(HEL)倡议结束成瘾,以加快对国家阿片类药物公共卫生危机的科学解决方案。 NIH Heal Heal倡议Bolsters在NIH跨NIH的研究,以改善阿片类药物滥用和成瘾的治疗方法,并制定能够为阿片类药物危机提供快速耐用的解决方案的具体策略。 SUD实施支持核心:项目摘要/抽象药物过量死亡人数继续增加主要投资,以开发和传播基于证据的药物使用障碍的药物和行为干预措施(SUDS)。由于将研究知识和基于证据的SUD干预措施转化为公共卫生实践的挑战,试图将过量死亡的针头转移。在整个美国卫生保健系统中,获得基于证据的SUD干预措施仍然受到严重限制,特别是对于历史上边缘化的人群,例如黑人/非裔美国人,夏威夷原住民/太平洋岛民,亚裔美国人和未投保的人。将研究结果公平地翻译成实践是传播和实施(D&I)科学的领域。 SUD实施支持(SUD-IS)核心将成为HD2A研究收养支持中心(RASC)的核心组成部分,它将为创新项目带来最好的D&I科学,以指导基于循证的,本地适当的SUD干预措施的选择,实施和维持,以减少硬命中率社区中过量的毒品风险。核心领导将统一实施科学家和SUD研究人员 - 近端目标是通过利用尖端的D&I措施和方法,并利用团队对团队科学的承诺来提高创新项目的影响和改善公共卫生的最终目标。 SUD-IS核心与RASC和其他核心在主题上和操作上,将通过动态和迭代阶段的评估,协助和进步来提升创新项目。我们将首先评估SUD干预措施的当前证据状态,以:a)制定基于证据和新兴实践的系统目录; b)基于五个关键D&I构造(例如,上下文确定者,对干预措施的基于证据的支持,利益相关者参与,实施策略以及包括公平和验收在内的实施成果),为创新项目和任何SUD干预实施项目开发SUD干预D&I资源指南。然后,我们将使用在评估阶段收集的信息来协助创新项目,以:a)通过限制核心专业知识的量身定制的D&I方法来增强他们的研究; b)提供D&I实施支持计划,并使用共同的决策方法来确定如何最好地提供技术帮助; c)共同领导RASC学习合作。最后,我们将推进创新项目在维持,公平和污名上的活动:将项目与整个领域联系起来,促进对政策/融资的影响,并支持正在进行的利益相关者参与倡导。与RASC完全保持一致,我们迈出了重大一步,旨在缩小证明SUD的药物和社会心理治疗的持续和不平等的差距。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sara J. Becker其他文献
Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
2006-2015 年镰状细胞病 ED 患者阿片类药物使用性别差异的评估。
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:3.6
- 作者:
T. Wilson;Shih;Sara J. Becker;J. Schuur;F. Beaudoin - 通讯作者:
F. Beaudoin
Brief Behavioral Interventions for Substance Use in Adolescents: A Meta-analysis
针对青少年药物滥用的简要行为干预:荟萃分析
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:8
- 作者:
D. Steele;Sara J. Becker;Kristin J. Danko;E. Balk;G. Adam;I. Saldanha;T. Trikalinos - 通讯作者:
T. Trikalinos
Evaluating approaches to marketing cognitive behavioral therapy: does evidence matter to consumers?
评估认知行为疗法的营销方法:证据对消费者重要吗?
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:4.7
- 作者:
C. Schofield;Gabriella T. Ponzini;Sara J. Becker - 通讯作者:
Sara J. Becker
Interventions for Substance Use Disorders in Adolescents: A Systematic Review
青少年药物使用障碍的干预措施:系统评价
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
D. Steele;Sara J. Becker;Kristin J. Danko;E. Balk;I. Saldanha;G. Adam;S. Bagley;C. Friedman;A. Spirito;Kelli Scott;E. Ntzani;Imani Saeed;Bryant T. Smith;J. Popp;T. Trikalinos - 通讯作者:
T. Trikalinos
Randomized Clinical Trials in Behavioral Medicine
行为医学随机临床试验
- DOI:
10.1007/978-0-387-93826-4_5 - 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
K. Freedland;Sara J. Becker;J. Blumenthal - 通讯作者:
J. Blumenthal
Sara J. Becker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sara J. Becker', 18)}}的其他基金
HD2A RASC-SUD Implementation Support Core
HD2A RASC-SUD 实施支持核心
- 批准号:
10708983 - 财政年份:2022
- 资助金额:
$ 59.12万 - 项目类别:
C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations
C-DIAS RP 2:在专业成瘾治疗组织中实施兴奋剂使用应急管理
- 批准号:
10668488 - 财政年份:2022
- 资助金额:
$ 59.12万 - 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
- 批准号:
10665470 - 财政年份:2022
- 资助金额:
$ 59.12万 - 项目类别:
C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations
C-DIAS RP 2:在专业成瘾治疗组织中实施兴奋剂使用应急管理
- 批准号:
10493960 - 财政年份:2022
- 资助金额:
$ 59.12万 - 项目类别:
Improving Outcomes of Adolescents in Residential Substance use Treatment via a Technology-Assisted Parenting Intervention
通过技术辅助育儿干预改善青少年住宅药物滥用治疗的结果
- 批准号:
10666175 - 财政年份:2021
- 资助金额:
$ 59.12万 - 项目类别:
Neighborhood perceptions and response to a technology-assisted parenting intervention for youth substance use
社区对针对青少年药物滥用的技术辅助育儿干预的看法和反应
- 批准号:
10836689 - 财政年份:2021
- 资助金额:
$ 59.12万 - 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
- 批准号:
10400426 - 财政年份:2018
- 资助金额:
$ 59.12万 - 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
- 批准号:
10215461 - 财政年份:2018
- 资助金额:
$ 59.12万 - 项目类别:
Adolescents with Substance Use Disorders Transitioning from Residential Treatment to the Community: Improving Outcomes via a Computer Assisted Parenting Program
患有药物滥用障碍的青少年从住院治疗过渡到社区:通过计算机辅助育儿计划改善治疗结果
- 批准号:
9034960 - 财政年份:2016
- 资助金额:
$ 59.12万 - 项目类别:
Adolescents with Substance Use Disorders Transitioning from Residential Treatment to the Community: Improving Outcomes via a Computer Assisted Parenting Program
患有药物滥用障碍的青少年从住院治疗过渡到社区:通过计算机辅助育儿计划改善治疗结果
- 批准号:
9263967 - 财政年份:2016
- 资助金额:
$ 59.12万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The RaDIANT Health Systems Intervention for Equity in Kidney Transplantation
Radiant 卫生系统干预肾移植的公平性
- 批准号:
10681998 - 财政年份:2023
- 资助金额:
$ 59.12万 - 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10855627 - 财政年份:2023
- 资助金额:
$ 59.12万 - 项目类别:
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
乌干达宫颈癌预防游戏规则改变者的混合实施-有效性试验
- 批准号:
10718609 - 财政年份:2023
- 资助金额:
$ 59.12万 - 项目类别:
NIDA Clinical Trials Network: New York Node - GY22 Integrating MOUD in Non-Medical Settings to Improve Treatment and Retention of Black/AA Persons
NIDA 临床试验网络:纽约节点 - GY22 在非医疗环境中整合 MOUD,以改善黑人/AA 人的治疗和保留
- 批准号:
10809985 - 财政年份:2023
- 资助金额:
$ 59.12万 - 项目类别:
Methadone Patient Access to Collaborative Treatment (MPACT)
美沙酮患者获得协作治疗 (MPACT)
- 批准号:
10812798 - 财政年份:2023
- 资助金额:
$ 59.12万 - 项目类别: